HealthEquity, Inc. (HQY) vs Ionis Pharmaceuticals, Inc. (IONS)

A side-by-side comparison of HealthEquity, Inc. and Ionis Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HQY vs IONS

growth of $100 · dividends reinvested · last 10y
HQY +141.4% (+9.2%/yr)IONS +22.0% (+2.0%/yr)HQY compounded faster over this window
100150200250300Start $10020182020202220242026$241$122
HQY IONS

HQY vs IONS: by the numbers

  • •HQY is the larger company ($7.61B vs $7.31B market cap).
  • •HQY is profitable (17.36% net margin) while IONS runs a net loss (-64.64%).
  • •HQY grew revenue faster over the past five years (12.96% vs 4.91% CAGR).

Metrics side by side

Valuation

MetricHQYIONS
P/E ratio32.87N/A
Forward P/E19.27N/A
PEG ratio0.40N/A
P/S ratio5.598.37
P/B ratio3.8216.63
EV / EBITDA17.312.21
FCF yield6.20%N/A

Profitability

MetricHQYIONS
Gross margin75.21%98.16%
Operating margin25.61%-40.47%
Net margin17.36%-64.64%
ROE11.88%-128.44%
ROIC8.55%-20.37%

Growth (annualized)

MetricHQYIONS
Revenue CAGR (5Y)12.96%4.91%
EPS CAGR (5Y)83.56%N/A
FCF CAGR (5Y)36.72%N/A
Total return CAGR (5Y)7.00%5.82%

Frequently asked

Which has grown faster, HQY or IONS?
Over the past five years, HQY grew revenue faster — HQY at a 12.96% CAGR versus IONS at 4.91%.
Is HQY or IONS more profitable?
HQY runs the higher net margin — HQY at 17.36% versus IONS at -64.64%.
How have HQY and IONS total returns compared?
Over the past 10 years, HQY delivered 9.16% and IONS delivered 1.80% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.